Those struggles would end, however, if all her future vaccinations could be delivered by a nasal spray. “Oh, my God, amazing!” Velasquez says. If you're enjoying this article, consider ...
The makers of a nasal spray launched last year by start-up Akita Biosciences have pulled back the curtain on how their product works (Adv. Mater. 2024, DOI: 10.1002/adma.202406348). The company ...
A new study details how a nasal spray formulated by investigators from Brigham and Women's Hospital may work to protect against viral and bacterial respiratory infections. Based on their ...
The U.S. Food and Drug Administration (FDA) has approved FluMist — the nasal spray flu vaccine — for home use by a patient or adult caregiver, the agency announced. FluMist has been in use for ...
The FDA has approved FluMist, a nasal spray flu vaccine, for self-administration. Healthy individuals aged 2 to 49 can use FluMist, but people with specific medical conditions or health concerns ...
Pathogens inhaled along with respiratory droplets enter through the nasal lining, causing respiratory infections. Brigham researchers have developed a pathogen capture and neutralizing spray ...